Smokeless Nicotine Seen as 'Bridge' For Military Members, Veterans Quitting Cigarettes

Why It Matters

Reducing cigarette use in the military cuts health costs, improves readiness, and opens a growing market for reduced‑risk nicotine products.

Key Takeaways

• 30% of service members use tobacco, double civilians
• DoD‑VA released first joint tobacco cessation guideline
• Smokeless nicotine seen as bridge to quitting cigarettes
• Leadership behavior influences troops' smoking habits
• Education needed on nicotine vs tobacco health risks

Pulse Analysis

The military’s tobacco problem is rooted in decades‑long culture, from World War II rations of cigarettes to modern deployment stressors. Recent Pentagon data show roughly one‑third of active‑duty members use some form of tobacco, a prevalence twice that of the civilian population. This high usage translates into elevated rates of cardiovascular disease, respiratory illness, and reduced operational readiness, driving the Department of Defense to treat tobacco use as a critical health‑and‑performance issue.

In response, the DoD and the Veterans Affairs department have issued a joint clinical practice guideline—the first of its kind—to standardize cessation efforts across the services. The guideline emphasizes nicotine‑replacement and smokeless products, such as pouches and vaping devices, as a “bridge” to eliminate the most harmful component of smoking: tar. Industry stakeholders, notably PMI US, argue that these smoke‑free alternatives deliver nicotine without the carcinogenic by‑products of combustion, aligning with broader public‑health harm‑reduction strategies. Leadership engagement is also pivotal; senior officers who model non‑smoking behavior can shift unit norms and accelerate adoption of cessation pathways.

For the commercial sector, the military’s pivot creates a sizable, captive market for reduced‑risk nicotine products. Companies that can navigate federal procurement rules and demonstrate clinical efficacy stand to capture significant share among service members and veterans. At the same time, regulators will scrutinize product safety and marketing claims to ensure they do not inadvertently encourage nicotine initiation. As the DoD‑VA framework matures, we can expect increased data on cessation outcomes, potentially shaping civilian public‑health policies and expanding the mainstream acceptance of smokeless nicotine as a legitimate cessation aid.